Hong Yu - Dec 7, 2022 Form 4 Insider Report for Biostage, Inc. (BSTG)

Role
PRESIDENT
Signature
/s/ Chad Porter, Attorney-in-Fact
Stock symbol
BSTG
Transactions as of
Dec 7, 2022
Transactions value $
$43
Form type
4
Date filed
12/9/2022, 04:21 PM
Previous filing
May 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSTG Common Stock Exercise of in-the-money or at-the-money derivative security $600K +300K +4889.98% $2.00 306K Dec 7, 2022 The spouse of the reporting person
transaction BSTG Common Stock Sale -$600K -83.7K -27.33% $7.17 222K Dec 7, 2022 The spouse of the reporting person F1
holding BSTG Common Stock 44.5K Dec 7, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSTG Warrants (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -300K -100% $0.00* 0 Dec 7, 2022 Common Stock 300K $2.00 The spouse of the reporting person F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 7, 2022, the Spouse of the Reporting Person exercised a warrant to purchase 300,000 shares of common stock for $2 per share. The Spouse of the Reporting Person paid the exercise price on a cashless basis, resulting in Biostage's withholding of 83,676 shares to pay the exercise price based on the daily VWAP of $7.1706, and issuing the remaining 216,324 shares of common stock.